4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-025665
Director acquired 233 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2021-04-05 | Grant or award | +233 | $37.51 | $8,740 | 82,157 | D |
Loading xslF345X03/doc4.xml…